These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38717147)

  • 21. Synthesis of a disaccharide repeating unit of the O-antigen from Burkholderia ambifaria and its oligomers.
    Wang D; Zhuge W; Guo Z; Gu G
    Carbohydr Res; 2017 Apr; 442():41-51. PubMed ID: 28288346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of the zwitterionic repeating unit of the O-antigen from Shigella sonnei and chain elongation at both ends.
    Pfister HB; Mulard LA
    Org Lett; 2014 Sep; 16(18):4892-5. PubMed ID: 25210812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of specifically deoxygenated disaccharide derivatives of the Shigella dysenteriae type 1 O-antigen.
    Mulard LA; Claudemans CP
    Carbohydr Res; 1995 Sep; 274():209-22. PubMed ID: 7585707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of hydrogen sulfide by two enzymes associated with biosynthesis of homocysteine and lanthionine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.
    Yoshida Y; Ito S; Kamo M; Kezuka Y; Tamura H; Kunimatsu K; Kato H
    Microbiology (Reading); 2010 Jul; 156(Pt 7):2260-2269. PubMed ID: 20413556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of Phenoxyundecyl Diphosphate Disaccharides for Studies of the Biosynthesis of O Antigenic Polysaccharides in Enteric Bacteria.
    Torgov V; Danilov L; Utkina N; Veselovsky V; Kocev A; Brockhausen I
    Methods Mol Biol; 2019; 1954():161-174. PubMed ID: 30864131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of a di- and a trisaccharide related to the O-antigen of Escherichia coli O83:K24:H31.
    Agnihotri G; Misra AK
    Carbohydr Res; 2006 Oct; 341(14):2420-5. PubMed ID: 16884704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
    mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of strain-specific PCR primers based on a DNA probe Fu12 for the identification of fusobacterium nucleatum subsp. nucleatum ATCC 25586T.
    Kim HS; Song SK; Yoo SY; Jin DC; Shin HS; Lim CK; Kim MS; Kim JS; Choe SJ; Kook JK
    J Microbiol; 2005 Aug; 43(4):331-6. PubMed ID: 16145547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The synthesis of chemically modified disaccharide derivatives of the Shigella flexneri Y polysaccharide antigen.
    Auzanneau FI; Hanna HR; Bundle DR
    Carbohydr Res; 1993 Feb; 240():161-81. PubMed ID: 7681359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the O-polysaccharide of Vibriocholerae O43 containing a new monosaccharide derivative, 4-(N-acetyl-l-allothreonyl)amino-4,6-dideoxy-D-glucose.
    Perepelov AV; Kocharova NA; Knirel YA; Jansson PE; Weintraub A
    Carbohydr Res; 2011 Feb; 346(3):430-3. PubMed ID: 21232736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Fusobacterium nucleatum and Porphyromonas gingivalis Lipopolysaccharides Clinically Isolated from Root Canal Infection in the Induction of Pro-Inflammatory Cytokines Secretion.
    Martinho FC; Leite FR; Nóbrega LM; Endo MS; Nascimento GG; Darveau RP; Gomes BP
    Braz Dent J; 2016; 27(2):202-7. PubMed ID: 27058385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Synthesis of terminal disaccharide of Forssman antigen and its analogs as spacer glycosides and free disaccharides].
    Ovchinnikova TV; Ter-Grigorian AG; Pazynina GV; Bovin NV
    Bioorg Khim; 1997 Jan; 23(1):61-74. PubMed ID: 9139645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an L-methionine γ-lyase involved in the production of hydrogen sulfide from L-cysteine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586.
    Suwabe K; Yoshida Y; Nagano K; Yoshimura F
    Microbiology (Reading); 2011 Oct; 157(Pt 10):2992-3000. PubMed ID: 21798982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strain-Specific Impact of Fusobacterium nucleatum on Neutrophil Function.
    Kurgan Ş; Kansal S; Nguyen D; Stephens D; Koroneos Y; Hasturk H; Van Dyke TE; Kantarci A
    J Periodontol; 2017 Apr; 88(4):380-389. PubMed ID: 27762731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of strain-specific PCR primers for the identification of Fusobacterium nucleatum subsp. fusiforme ATCC 51190(T) and subsp. vincentii ATCC 49256(T).
    Shin HS; Kim MJ; Kim HS; Park SN; Kim DK; Baek DH; Kim C; Kook JK
    Anaerobe; 2010 Feb; 16(1):43-6. PubMed ID: 19398030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of 1D-(1,3,5/2,4)-4-acetamido-5-amino-1,2,3-cyclohexanetriol and its incorporation into a pseudo-disaccharide.
    Wang LX; Sakairi N; Kuzuhara H
    Carbohydr Res; 1995 Sep; 275(1):33-47. PubMed ID: 7585723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer.
    Chen L; Zhao R; Shen J; Liu N; Zheng Z; Miao Y; Zhu J; Zhang L; Wang Y; Fang H; Zhou J; Li M; Yang Y; Liu Z; Chen Q
    Adv Mater; 2023 Nov; 35(45):e2306281. PubMed ID: 37722134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A chemical and biological toolbox for Type Vd secretion: Characterization of the phospholipase A1 autotransporter FplA from
    Casasanta MA; Yoo CC; Smith HB; Duncan AJ; Cochrane K; Varano AC; Allen-Vercoe E; Slade DJ
    J Biol Chem; 2017 Dec; 292(49):20240-20254. PubMed ID: 29021252
    [No Abstract]   [Full Text] [Related]  

  • 40. FAD-I, a Fusobacterium nucleatum Cell Wall-Associated Diacylated Lipoprotein That Mediates Human Beta Defensin 2 Induction through Toll-Like Receptor-1/2 (TLR-1/2) and TLR-2/6.
    Bhattacharyya S; Ghosh SK; Shokeen B; Eapan B; Lux R; Kiselar J; Nithianantham S; Young A; Pandiyan P; McCormick TS; Weinberg A
    Infect Immun; 2016 May; 84(5):1446-1456. PubMed ID: 26930710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.